EMA Recommends Approval of Capvaxive Pneumococcal Vaccine

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

The medicines regulator has endorsed Merck’s 21-valent pneumococcal vaccine for adults.
Medscape Medical News